Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo

Journal of Clinical Virology

Volumn 57, Issue 2, 2013, Pages 161-164

  Alidjinou, E K ^a   Ebatetou Ataboho, E ^b   Sane F ^a   Moukassa, D ^b   Dewilde, A ^a   Hober, D ^a  

^a University Lille   (France)

^b Laboratoire d'Analyses Médicales et Morphologiques Hôpital Général de Loandjili   (Congo)

Author keywords

Dried samples; Filter paper; HR HPV; Hybrid capture 2; Vaginal tampons

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONGO; DEVICES; FEMALE; FILTER PAPER; HIGH RISK POPULATION; HUMAN; INFECTION RISK; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TAMPON; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

CERVIX UTERI; CONGO; DESICCATION; DNA, VIRAL; FEMALE; FILTRATION; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MENSTRUAL HYGIENE PRODUCTS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS;

EID: 84876966159     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.02.010     Document Type: Article

References (30)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
2. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-459.
3. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) Human Papillomavirus and Related Cancers in Congo. Summary Report 2010 2010, Available from: http://www.who.int/hpvcentre (accessed 25.8.12).
4. Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87(11):796-802.
5. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol 2010, 117:S5-S10.
6. Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006, 119(5):1095-1101.
7. Naucler P., Ryd W., Törnberg S., Strand A., Wadell G., Elfgren K., et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007, 357(16):1589-1597.
8. Rijkaart D.C., Berkhof J., Rozendaal L., van Kemenade F.J., Bulkmans N.W., Heideman D.A., et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 2012, 13(1):78-88.
9. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998.
10. Zaravinos A., Mammas I.N., Sourvinos G., Spandidos D.A. Molecular detection methods of human papillomavirus (HPV). Int J Biol Markers 2009, 24(4):215-222.
11. Molijn A., Kleter B., Quint W., van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005, 32(Suppl. 1):S43-S51.
12. Lorincz A.T. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996, 22:629-636.
13. Daponte A., Tsezou A., Oikonomou P., Hadjichristodoulou C., Maniatis A.N., Pournaras S., et al. Use of real-time PCR to detect human papillomavirus-16 viral loads in vaginal and urine self-sampled specimens. Clin Microbiol Infect 2008, 14(6):619-621.
14. Mei J.V., Alexander J.R., Adam B.W., Hannon W.H. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001, 131(5):1631S-1636S.
15. Kailash U., Hedau S., Gopalkrishna V., Katiyar S., Das B.C. A simple 'paper smear' method for dry collection, transport and storage of cervical cytological specimens for rapid screening of HPV infection by PCR. J Med Microbiol 2002, 51(7):606-610.
16. Banura C., Franceschi S., van Doorn L.J., Wabwire-Mangen F., Mbidde E.K., Weiderpass E. Detection of cervical human papillomavirus infection in filter paper samples: a comparative study. J Med Microbiol 2008, 57(Pt 2):253-255.
17. Gustavsson I., Lindell M., Wilander E., Strand A., Gyllensten U. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol 2009, 46(2):112-116.
18. Shukla S., Bharti A.C., Mahata S., Hussain S., Hedau S., Sharma R., et al. Application of a multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses (HPVs) and typing of high-risk HPV types 16 and 18. J Med Microbiol 2010, 59(Pt 11):1303-1310.
19. Schmeink C.E., Bekkers R.L., Massuger L.F., Melchers W.J. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol 2011, 21(3):139-153.
20. Snijders P.J., Verhoef V.M., Arbyn M., Ogilvie G., Minozzi S., Banzi R., et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2012, 10.1002/ijc.27790.
21. Fairley C.K., Chen S., Tabrizi S.N., Quinn M.A., McNeil J.J., Garland S.M. Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis 1992, 165:1103-1106.
22. Coutlee F., Hankins C., Lapointe N. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by polymerase chain reaction. J Med Virol 1997, 51:42-47. The Canadian Women's HIV Study Group.
23. Jones H.E., Allan B.R., van de Wijgert J.H., Altini L., Taylor S.M., de Kock A., et al. Agreement between self and clinician collected specimen result for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa. J Clin Microbiol 2007, 45(6):1679-1683.
24. Ogilvie G.S., Patrick D.M., Schulzer M., Sellors J.W., Petric M., Chambers K and al Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005, 81(3):207-212.
25. Castellsagué X., Menéndez C., Loscertales M.P., Kornegay J.R., dos Santos F., Gómez-Olivé F.X., et al. Human papillomavirus genotypes in rural Mozambique. Lancet 2001, 358:1429-1430.
26. Didelot-Rousseau M.N., Nagot N., Costes-Martineau V., Vallès X., Ouedraogo A., Konate I., et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer 2006, 95:355-362.
27. Hameed M., Fernandes H. Human papillomavirus typing in HIV-positive women. Infect Dis Obstet Gynecol 2001, 28:125-130.
28. Broker T.R., Jin G., Croom-Rivers A., Bragg S.M., Richardson M., Chow L.T., et al. Viral latency: the papillomavirus model. Dev Biol 2001, 106:443-451.
29. Levi J.E., Kleter B. High prevalence of human papillomavirus infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40(9):3341-3345.
30. Bayo S., Bosch F.X., de Sanjosé S., Muñoz N., Combita A.L., Coursaget P., et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002, 31:202-209.